Tenderwize
Retour à la recherche

Open-house rebate agreements for Tacrolimus

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 644 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tacrolimus, ATC L04AD02

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

58 / 100

Facteurs de risque

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Non-exclusive rebate agreements for pharmaceutical products containing Tacrolimus, ATC L04AD02.
  • Open-house model with identical contract terms for all eligible pharmaceutical companies.
Afficher le résumé complet

This is an open-house pharmaceutical supply arrangement for Tacrolimus (CPV 33600000) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated eligibility condition can conclude identical, non-negotiable, non-exclusive rebate agreements. The contract period runs from 2026-08-01 to 2028-07-31, with contract entry possible at any time until 2028-06-03. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German-language requirements apply, and non-German documents must be submitted with a German translation.

Risques

The notice uses an open-procedure form but states that the arrangement is actually an open-house model outside ordinary...

Submission must go through the DTVP communication area, not the offer area; paper originals must arrive in duplicate an...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The contract and the annex 'Determination of the contract products' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability must be submitted.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Tacrolimus

Open-house supply arrangement for Tacrolimus, ATC L04AD02, for pharmaceutical companies. The lot is described as a non-exclusive rebate agreement model with identical, non-individually negotiable contract terms. Performance is in Germany (DE212).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jul 2026 - Jul 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Jun 03, 2028

Détails de la procédure

Date de publication
14 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
409342-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30